Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis

by Broder, M.S, Chang, E., Corral, M., Gokhale, S., Mooney, J., Reddy, S.R
Published 2021

LC-MS lipidomics of renal biopsies for the diagnosis of Fabry disease

by Bazargani, S.F, Clapp, W.L, Garrett, T.J, Heldermon, C., King-Morris, K., Segal, M.S, Vanbeek, C.A, Yazd, H.S
Published 2021

A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese

by Cheng, Z., Deng, Y., Fang, S., Ge, R., Li, J., Li, Z., Liu, J., Luo, G., Mo, B., Peng, Q., Shu, Y., Wang, X., Wang, Y., Wang, Z., Wei, G., Wei, J., Wu, M., Xiong, W., Xu, X., Yang, H., Yang, J., Yang, S., Zhang, X., Zhu, J.
Published 2021

Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mou...

by Dai, H., Gao, T., Hao, J., Li, Y., Liu, P., Song, D., Wang, C., Wang, L., Wang, Z., Wu, J., Yang, S., Zhao, X.
Published 2022

Air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Beijing: a time-series study

by Cai, Y., Chu, S., Jing, H., Liang, L., Lyu, B., Rahimi, K., Tong, Z., Zhang, D.
Published 2022

PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model

by Chao, Z., Chen, J., Dong, H., Jia, C., Liang, J., Liu, X., Liu, Z., Qin, H., Qin, X., Yuan, Y., Zhang, H., Zhang, Z.
Published 2022